Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | GSK3B | P49841 | 2/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3021179 | 0.82 | TRPA1 (0.35) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL910448 | 0.78 | DAO (0.38) | TDP1CYP1A2FFAR1 | |
| SCHEMBL9036603 | 0.78 | TAAR1 (0.50) | CYP1A2TAAR1 | |
| SCHEMBL5728797 | 0.78 | CYP19A1 (0.43) | TDP1CYP1A1CYP1A2CYP1B1FFAR1 | |
| SCHEMBL30252315 | 0.78 | CYP19A1 (0.43) | TDP1CYP1A1CYP1A2CYP1B1FFAR1 | |
| SCHEMBL6210675 | 0.77 | HTR1A (0.44) | TDP1FFAR1TAAR1 | |
| SCHEMBL30600 | 0.75 | TDP1 (0.55) | TDP1PTPN1GSK3BCYP1A1CYP1A2 | |
| SCHEMBL2119420 | 0.75 | CYP3A4 (0.44) | TDP1CYP1A2 | |
| SCHEMBL3822531 | 0.75 | ALDH1A1 (0.35) | — | |
| SCHEMBL535892 | 0.75 | GABRA1 (0.45) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101522657-B | STAT3/5 activation inhibitor | OTSUKA PHARMACEUTICAL CO.,LTD. (JP) | 2014-10-15 | — | — | CN | disclosed |
| CN-1993339-B | Aromatic compound | OTSUKA PHARMA CO LTD | 2013-05-22 | — | — | CN | disclosed |
| CN-101522657-A | STAT3/5 activation inhibitor | OTSUKA PHARMA CO LTD (JP) | 2009-09-02 | — | — | CN | disclosed |
| CN-1993339-A | Aromatic compound | OTSUKA PHARMA CO LTD (JP) | 2007-07-04 | — | — | CN | disclosed |
| CN-1114590-C | Unsaturated oximino ether bactericide | SHENYAN CHEMICAL ENGINEERING I (CN) | 2003-07-16 | — | — | CN | disclosed |
| CN-1169989-A | Process for preparing dithiocarbonimide derivatives | SUMITOMO CHEMICAL CO (JP) | 1998-01-14 | — | — | CN | disclosed |
| US-5098996-A | Fluorination of compounds for use in diagnosis of nuclear medicine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-03-24 | — | — | US | disclosed |